Indomethacin 50 MG suppository 30S
Ended Awarded
- Contract number
- SPE2DB25FP8X9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,169
Award facts
- Contract value 100% obligated
- $26,169.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,169.09 to AmerisourceBergen Drug Corp for the supply of Indomethacin 50 mg suppositories (30-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency and its Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Indomethacin, a nonsteroidal anti-inflammatory medication commonly used in military and veteran healthcare systems, reflects the company's ongoing role as a primary pharmaceutical supplier for the Department of Defense and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FP8X9?
SPE2DB25FP8X9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FP8X9 worth?
The government has obligated $26,169 on SPE2DB25FP8X9.
Is contract SPE2DB25FP8X9 an order under another contract?
Yes. SPE2DB25FP8X9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP8X9 competed?
The extent of competition for SPE2DB25FP8X9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award